Adaptimmune Therapeutics (ADAPY) Q2 2024 Earnings Report

1,252 Followers

ADAPY Q2 2024 EPS Results

Actual EPS$0.04

Consensus EPS-$0.04

Beat/MissBeat by +$0.08

One Year Ago EPS-$0.02

Actual Revenue$128.37M

Expected Revenue$40.47M

Beat/MissBeat by +$87.90M

YoY Revenue Growth+2393.48%

QuarterQ2 2024

Date08/12/2024

TimeBefore Open

Conference CallMonday, August 12, 2024

ADAPY Q2 2024 Earnings Call

0:00 / 0:00

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Aug 12, 2026	2026 (Q2)	- / -	-0.116	―
May 20, 2026	2026 (Q1)	-0.03 / -	-0.03	―
Mar 10, 2026	2025 (Q4)	-0.06 / -0.03	-0.05	40.00% (+0.02)
Nov 05, 2025	2025 (Q3)	-0.12 / -	-0.01	―
Aug 13, 2025	2025 (Q2)	-0.04 / -0.02	0.04	-150.00% (-0.06)
May 13, 2025	2025 (Q1)	-0.09 / -0.03	-0.03	0.00% (0.00)
Mar 20, 2025	2024 (Q4)	-0.03 / -0.05	-0.04	-25.00% (-0.01)
Nov 13, 2024	2024 (Q3)	>-0.01 / -0.01	-0.03	66.67% (+0.02)
Aug 12, 2024	2024 (Q2)	-0.04 / 0.04	-0.02	300.00% (+0.06)
May 15, 2024	2024 (Q1)	-0.15 / -0.03	0	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed